Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Microfluidic Device for Screening for Target Cell-Specific Binding Molecules by Using Adherent Cells.

Kaminaga M, Ishida T, Kadonosono T, Kizaka-Kondoh S, Omata T.

Micromachines (Basel). 2019 Jan 9;10(1). pii: E41. doi: 10.3390/mi10010041.

2.

A reliable murine model of bone metastasis by injecting cancer cells through caudal arteries.

Kuchimaru T, Kataoka N, Nakagawa K, Isozaki T, Miyabara H, Minegishi M, Kadonosono T, Kizaka-Kondoh S.

Nat Commun. 2018 Jul 30;9(1):2981. doi: 10.1038/s41467-018-05366-3.

3.

Novel lymphoid enhancer-binding factor 1-cytoglobin axis promotes extravasation of osteosarcoma cells into the lungs.

Pongsuchart M, Kuchimaru T, Yonezawa S, Tran DTP, Kha NT, Hoang NTH, Kadonosono T, Kizaka-Kondoh S.

Cancer Sci. 2018 Sep;109(9):2746-2756. doi: 10.1111/cas.13702. Epub 2018 Jul 24.

4.

Cyclic Peptides for Efficient Detection of Collagen.

Takita KK, Fujii KK, Kadonosono T, Masuda R, Koide T.

Chembiochem. 2018 Aug 6;19(15):1613-1617. doi: 10.1002/cbic.201800166. Epub 2018 Jun 21.

PMID:
29756312
5.

Novel adherent CD11b+ Gr-1+ tumor-infiltrating cells initiate an immunosuppressive tumor microenvironment.

Tsubaki T, Kadonosono T, Sakurai S, Shiozawa T, Goto T, Sakai S, Kuchimaru T, Sakamoto T, Watanabe H, Kondoh G, Kizaka-Kondoh S.

Oncotarget. 2018 Jan 29;9(13):11209-11226. doi: 10.18632/oncotarget.24359. eCollection 2018 Feb 16.

6.

Domain architecture of vasohibins required for their chaperone-dependent unconventional extracellular release.

Kadonosono T, Yimchuen W, Tsubaki T, Shiozawa T, Suzuki Y, Kuchimaru T, Sato Y, Kizaka-Kondoh S.

Protein Sci. 2017 Mar;26(3):452-463. doi: 10.1002/pro.3089. Epub 2017 Feb 11.

7.

A novel injectable BRET-based in vivo imaging probe for detecting the activity of hypoxia-inducible factor regulated by the ubiquitin-proteasome system.

Kuchimaru T, Suka T, Hirota K, Kadonosono T, Kizaka-Kondoh S.

Sci Rep. 2016 Oct 4;6:34311. doi: 10.1038/srep34311.

8.

A luciferin analogue generating near-infrared bioluminescence achieves highly sensitive deep-tissue imaging.

Kuchimaru T, Iwano S, Kiyama M, Mitsumata S, Kadonosono T, Niwa H, Maki S, Kizaka-Kondoh S.

Nat Commun. 2016 Jun 14;7:11856. doi: 10.1038/ncomms11856.

9.

Hypoxia-inducible factor-targeting prodrug TOP3 combined with gemcitabine or TS-1 improves pancreatic cancer survival in an orthotopic model.

Hoang NT, Kadonosono T, Kuchimaru T, Kizaka-Kondoh S.

Cancer Sci. 2016 Aug;107(8):1151-8. doi: 10.1111/cas.12982. Epub 2016 Jul 21.

10.

Distinctive role of vasohibin-1A and its splicing variant vasohibin-1B in tumor angiogenesis.

Horie S, Suzuki Y, Kobayashi M, Kadonosono T, Kondoh S, Kodama T, Sato Y.

Cancer Gene Ther. 2016 May;23(5):133-41. doi: 10.1038/cgt.2016.13. Epub 2016 Apr 15.

PMID:
27080222
11.

VEGF-A/NRP1 stimulates GIPC1 and Syx complex formation to promote RhoA activation and proliferation in skin cancer cells.

Yoshida A, Shimizu A, Asano H, Kadonosono T, Kondoh SK, Geretti E, Mammoto A, Klagsbrun M, Seo MK.

Biol Open. 2015 Jul 24;4(9):1063-76. doi: 10.1242/bio.010918.

12.

High resolution imaging of intracellular oxygen concentration by phosphorescence lifetime.

Kurokawa H, Ito H, Inoue M, Tabata K, Sato Y, Yamagata K, Kizaka-Kondoh S, Kadonosono T, Yano S, Inoue M, Kamachi T.

Sci Rep. 2015 Jun 12;5:10657. doi: 10.1038/srep10657.

13.

Cell penetrating peptides improve tumor delivery of cargos through neuropilin-1-dependent extravasation.

Kadonosono T, Yamano A, Goto T, Tsubaki T, Niibori M, Kuchimaru T, Kizaka-Kondoh S.

J Control Release. 2015 Mar 10;201:14-21. doi: 10.1016/j.jconrel.2015.01.011. Epub 2015 Jan 13.

PMID:
25592386
14.

A fluorescent protein scaffold for presenting structurally constrained peptides provides an effective screening system to identify high affinity target-binding peptides.

Kadonosono T, Yabe E, Furuta T, Yamano A, Tsubaki T, Sekine T, Kuchimaru T, Sakurai M, Kizaka-Kondoh S.

PLoS One. 2014 Aug 1;9(8):e103397. doi: 10.1371/journal.pone.0103397. eCollection 2014.

15.

Bone resorption facilitates osteoblastic bone metastatic colonization by cooperation of insulin-like growth factor and hypoxia.

Kuchimaru T, Hoshino T, Aikawa T, Yasuda H, Kobayashi T, Kadonosono T, Kizaka-Kondoh S.

Cancer Sci. 2014 May;105(5):553-9. doi: 10.1111/cas.12391. Epub 2014 Apr 3.

16.

In vivo imaging of brain ischemia using an oxygen-dependent degradative fusion protein probe.

Fujita Y, Kuchimaru T, Kadonosono T, Tanaka S, Hase Y, Tomimoto H, Hiraoka M, Kizaka-Kondoh S, Ihara M, Takahashi R.

PLoS One. 2012;7(10):e48051. doi: 10.1371/journal.pone.0048051. Epub 2012 Oct 19.

17.

Development of a hypoxia-selective near-infrared fluorescent probe for non-invasive tumor imaging.

Youssif BG, Okuda K, Kadonosono T, Salem OI, Hayallah AA, Hussein MA, Kizaka-Kondoh S, Nagasawa H.

Chem Pharm Bull (Tokyo). 2012;60(3):402-7.

18.

2-Nitroimidazole-tricarbocyanine conjugate as a near-infrared fluorescent probe for in vivo imaging of tumor hypoxia.

Okuda K, Okabe Y, Kadonosono T, Ueno T, Youssif BG, Kizaka-Kondoh S, Nagasawa H.

Bioconjug Chem. 2012 Mar 21;23(3):324-9. doi: 10.1021/bc2004704. Epub 2012 Feb 22.

PMID:
22335430
19.

Detection of the onset of ischemia and carcinogenesis by hypoxia-inducible transcription factor-based in vivo bioluminescence imaging.

Kadonosono T, Kuchimaru T, Yamada S, Takahashi Y, Murakami A, Tani T, Watanabe H, Tanaka T, Hirota K, Inoue M, Tsukamoto T, Toyoda T, Urano K, Machida K, Eto T, Ogura T, Tsutsumi H, Ito M, Hiraoka M, Kondoh G, Kizaka-Kondoh S.

PLoS One. 2011;6(11):e26640. doi: 10.1371/journal.pone.0026640. Epub 2011 Nov 10.

20.
21.

In vivo imaging of HIF-active tumors by an oxygen-dependent degradation protein probe with an interchangeable labeling system.

Kuchimaru T, Kadonosono T, Tanaka S, Ushiki T, Hiraoka M, Kizaka-Kondoh S.

PLoS One. 2010 Dec 23;5(12):e15736. doi: 10.1371/journal.pone.0015736.

22.

Alteration of substrate specificity of rat neurolysin from matrix metalloproteinase-2/9-type to -3-type specificity by comprehensive mutation.

Kadonosono T, Kato-Murai M, Ueda M.

Protein Eng Des Sel. 2008 Aug;21(8):507-13. doi: 10.1093/protein/gzn026. Epub 2008 May 21.

PMID:
18499680
23.

Design of a serine protease-like catalytic triad on an antibody light chain displayed on the yeast cell surface.

Okochi N, Kato-Murai M, Kadonosono T, Ueda M.

Appl Microbiol Biotechnol. 2007 Dec;77(3):597-603. Epub 2007 Sep 27.

PMID:
17899065
24.

Enhancement of substrate recognition ability by combinatorial mutation of beta-glucosidase displayed on the yeast cell surface.

Fukuda T, Kato-Murai M, Kadonosono T, Sahara H, Hata Y, Suye S, Ueda M.

Appl Microbiol Biotechnol. 2007 Oct;76(5):1027-33. Epub 2007 Jun 30.

PMID:
17602218
25.

Metallopeptidase, neurolysin, as a novel molecular tool for analysis of properties of cancer-producing matrix metalloproteinases-2 and -9.

Kadonosono T, Kato M, Ueda M.

Appl Microbiol Biotechnol. 2007 Jul;75(6):1285-91. Epub 2007 Apr 3.

PMID:
17404728
26.

Substrate specificity of rat brain neurolysin disclosed by molecular display system and putative substrates in rat tissues.

Kadonosono T, Kato M, Ueda M.

Appl Microbiol Biotechnol. 2007 Jul;75(6):1353-60. Epub 2007 Mar 31.

PMID:
17401561
27.

Construction of a novel synergistic system for production and recovery of secreted recombinant proteins by the cell surface engineering.

Shibasaki S, Kawabata A, Ishii J, Yagi S, Kadonosono T, Kato M, Fukuda N, Kondo A, Ueda M.

Appl Microbiol Biotechnol. 2007 Jun;75(4):821-8. Epub 2007 Mar 8.

PMID:
17345082
28.

Minimization of cavity size ensures protein stability and folding: structures of Phe46-replaced bovine pancreatic RNase A.

Kadonosono T, Chatani E, Hayashi R, Moriyama H, Ueki T.

Biochemistry. 2003 Sep 16;42(36):10651-8.

PMID:
12962489

Supplemental Content

Loading ...
Support Center